492 related articles for article (PubMed ID: 23975287)
1. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.
Connor C; McGinness M; Mammen J; Ranallo L; Lafaver S; Klemp J; Fan F; Mahnken J
Ann Surg Oncol; 2013 Oct; 20(10):3303-7. PubMed ID: 23975287
[TBL] [Abstract][Full Text] [Related]
2. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
3. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
[TBL] [Abstract][Full Text] [Related]
4. Is axillary reverse mapping feasible in breast cancer patients?
Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
[TBL] [Abstract][Full Text] [Related]
5. Axillary reverse mapping in breast cancer: a Canadian experience.
Kuusk U; Seyednejad N; McKevitt EC; Dingee CK; Wiseman SM
J Surg Oncol; 2014 Dec; 110(7):791-5. PubMed ID: 25053441
[TBL] [Abstract][Full Text] [Related]
6. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
[TBL] [Abstract][Full Text] [Related]
7. The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
Han C; Yang B; Zuo WS; Zheng G; Yang L; Zheng MZ
PLoS One; 2016; 11(2):e0150285. PubMed ID: 26919589
[TBL] [Abstract][Full Text] [Related]
8. Axillary reverse mapping: five-year experience.
Ochoa D; Korourian S; Boneti C; Adkins L; Badgwell B; Klimberg VS
Surgery; 2014 Nov; 156(5):1261-8. PubMed ID: 25444319
[TBL] [Abstract][Full Text] [Related]
9. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation.
Thompson M; Korourian S; Henry-Tillman R; Adkins L; Mumford S; Westbrook KC; Klimberg VS
Ann Surg Oncol; 2007 Jun; 14(6):1890-5. PubMed ID: 17479341
[TBL] [Abstract][Full Text] [Related]
10. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
[TBL] [Abstract][Full Text] [Related]
11. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
[TBL] [Abstract][Full Text] [Related]
12. Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.
Boneti C; Badgwell B; Robertson Y; Korourian S; Adkins L; Klimberg V
Minerva Ginecol; 2012 Oct; 64(5):421-30. PubMed ID: 23018481
[TBL] [Abstract][Full Text] [Related]
13. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
14. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
15. Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer.
Noguchi M; Yokoi M; Nakano Y
J Surg Oncol; 2010 Mar; 101(3):217-21. PubMed ID: 20063370
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.
Ikeda K; Ogawa Y; Komatsu H; Mori Y; Ishikawa A; Nakajima T; Oohira G; Tokunaga S; Fukushima H; Inoue T
World J Surg Oncol; 2012 Nov; 10():233. PubMed ID: 23116152
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.
Noguchi M; Noguchi M; Ohno Y; Morioka E; Nakano Y; Kosaka T; Kurose N; Minato H
Eur J Surg Oncol; 2016 May; 42(5):650-6. PubMed ID: 27005806
[TBL] [Abstract][Full Text] [Related]
19. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
20. Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy.
Boneti C; Korourian S; Diaz Z; Santiago C; Mumford S; Adkins L; Klimberg VS
Am J Surg; 2009 Oct; 198(4):482-7. PubMed ID: 19800452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]